Patheon (Booth 1232) has named William E. Weiser, Ph.D. to the role of group director, Pharmaceutical Development Services (PDS), Analytical Development at the company's Kit Creek laboratory in Research Triangle Park, NC. Also, Anthony Qu, Ph.D. has been named group director of the PDS operation in Cincinnati, OH.
"We are so pleased that we have been able to add these two individuals to our organization," said Dr. Colin Minchom, Patheon's vice president PDS North America. "I am confident that our customers and employees will benefit from their broad expertise as leaders and as scientists in research and development."
Dr. Weiser has over 20 years experience in the pharmaceutical industry. Most recently he served as general manager for Liquidia Pharmaceuticals with responsibility for establishing pharmaceutical development operations for nanoparticle therapeutics as well as formulation and analytical development capabilities. He was vice president of analytical chemistry at Cardinal Health/Magellan Laboratories, where he contributed to the growth of their contract pharmaceutical analytical services business. Dr. Weiser also held positions of increasing leadership in Pharmaceutical Development at Burroughs Wellcome Co.
Dr. Qu, with almost 20 years experience in the pharmaceutical industry, is returning to Patheon from his most recent position as vice president of product development at Apotex. His previous Patheon experience included responsibilities as senior director of PDS Global Analytical Operations and director/manager, PDS Analytical Development in Mississauga, ONT, Canada. He has also held positions in R&D and regulatory affairs at Biovail and Taro Pharmaceuticals.
Visit Patheon at Booth 1232!
Magazine
